KRAS and colorectal carcinoma: Meanwhile, ERN1-JNK-JUN pathway was identified as a bypass cell signaling that mediates resistance to MEK inhibitor in KRAS mutant CRC cells through a synthetic lethal CRISPR-Cas9 screening.